FDA Regulated Research: Innovation & Compliance
The Ohio State University Office of Responsible Research Practices in collaboration with the Center for Clinical and Translational Science and Nationwide Children’s Hospital will host an FDA-focused conference entitled “FDA Regulated Research: Innovation & Compliance.” The conference will host a number of speakers from industry, regulatory experts, The Ohio State University, Wexner Medical Center, Comprehensive Cancer Center, and Nationwide Children’s Hospital and will focus on the following key topics:
- Drug Development and Innovation
- Device Innovation
- Investigator Responsibilities
- Partnerships with Industry
- Innovation and Drug Development Strategies
- Keys to Successful Translational Research
- FDA Inspections
- Research Resources Panel Discussion
This event has reached capacity. Registration is closed.
Contact: John Yocom at firstname.lastname@example.org.
|Who:||Anyone interested in FDA regulated research|
|When:||March 3, 2017, 8:15 a.m. – 3:30 p.m.
Registration opens at 7:30 a.m.
|Where:||The Ohio State University
Biomedical Research Tower, Room 115
460 W 12th Ave, Columbus, OH 43210
Attendance at this event has been pre‐approved for contact hours of clinical research-related education on applications for Maintenance of ACRP’s CCRC®, CCRA®, or CPI® certification designations.